BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,975,227 | -30.9% | 82,130 | -8.3% | 0.00% | 0.0% |
| Q2 2023 | $2,858,693 | +33.2% | 89,530 | +27.7% | 0.00% | 0.0% |
| Q1 2023 | $2,146,462 | -21.7% | 70,100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,741,611 | -17.9% | 70,100 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,340,000 | +23.6% | 70,100 | +0.4% | 0.00% | +100.0% |
| Q2 2022 | $2,702,000 | -16.7% | 69,800 | +23.3% | 0.00% | 0.0% |
| Q1 2022 | $3,243,000 | -27.9% | 56,600 | +0.4% | 0.00% | -50.0% |
| Q4 2021 | $4,495,000 | -8.4% | 56,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,907,000 | -29.9% | 56,400 | +3.7% | 0.00% | -33.3% |
| Q2 2021 | $7,002,000 | +74.6% | 54,400 | +8.6% | 0.00% | +50.0% |
| Q1 2021 | $4,010,000 | -2.0% | 50,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,090,000 | +257.2% | 50,100 | +7.7% | 0.00% | +100.0% |
| Q3 2020 | $1,145,000 | +42.4% | 46,500 | +62.0% | 0.00% | – |
| Q2 2020 | $804,000 | +302.0% | 28,700 | +158.6% | 0.00% | – |
| Q1 2020 | $200,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |